secwatch.observer — SEC 8-K summary
======================================

Issuer:     Jaguar Health, Inc. (JAGX)
CIK:        0001585608
Form:       8-K
Filed at:   2026-07-14T20:15:12+00:00
Accession:  0001193125-26-303190
Event type: other_material
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Jaguar Health subsidiary Napo enters new 3-year manufacturing agreement with Alivus for crofelemer supply
--------------------------------------------------------------------------------

- New agreement with Alivus Life Sciences for manufacture of crofelemer for Mytesi and other products.
- Term from July 9, 2026 to March 31, 2029; replaces prior agreement that expired March 31, 2026.
- Includes minimum purchase quantities; shortfall payment obligation if not met.
- May be terminated for any reason with 12 months' notice, or for material breach with 90-day cure.
- In insolvency, rights assigned to Woodward Specialty LLC (affiliate of Future Pak).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526303190/0001193125-26-303190-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1585608/000119312526303190/d144017d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-26-303190

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer